Immutep

+$0.02 (+0.74%) Today

$0.00 (0.00%) As of 8:25 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.

About IMMP

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma.

CEO

Marc Voigt

Employees

—

Headquarters

Sydney, New South Wales (NSW)

Founded

1987

IMMP Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

75.34K

High today

$2.74

Low today

$2.66

Open price

$2.68

Volume

46.89K

52 Week high

$5.44

52 Week low

$2.02

IMMP News

Simply Wall StMay 19

Is Immutep Weighed On By Its Debt Load? - Simply Wall St

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how ris

Analyst ratings

Buy

100%

Hold

Sell

IMMP Earnings

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Jul 30, Pre-Market

Why Robinhood?

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. View more

Is Immutep Weighed On By Its Debt Load? - Simply Wall St

100%

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma.